Compile Data Set for Download or QSAR
Report error Found 316 of ic50 data for polymerid = 9636
TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423017(US10508109, Example 203 | dimethyl (4-(2-(5-chloro...)
Affinity DataIC50: 1.77nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423023(US10508109, Example 209 | 3-(2-(7-(1,4-diazepan-1-...)
Affinity DataIC50: 2.07nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423039(US10508109, Example 225 | N1-(2-(5-chloro-2,4- dim...)
Affinity DataIC50: 2.20nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422884(US10508109, Example 75 | N1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 2.71nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423024(US10508109, Example 210 | diethyl (2-(4-(2-(5-chlo...)
Affinity DataIC50: 2.90nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422944(US10508109, Example 130 | 3-(4-(2-(5-bromo-2,4- di...)
Affinity DataIC50: 3nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422805(US10508109, Example 4 | 2-(5-chloro-2,4- dimethoxy...)
Affinity DataIC50: 3.10nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422936(US10508109, Example 124 | N-(1-(2-(5-chloro-2,4- d...)
Affinity DataIC50: 3.27nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423089(US10508109, Example 275 | tert-butyl 4-(2-(5-chlor...)
Affinity DataIC50: 3.33nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422898(US10508109, Example 89 | N1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 3.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422945(US10508109, Example 131 | 4-(2-(4-(2-(5-bromo-2,4-...)
Affinity DataIC50: 3.49nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422972(US10508109, Example 158 | 3-(4-(2-(5-chloro-2,4- d...)
Affinity DataIC50: 3.53nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422858(US10508109, Example 49 | 2,4-dimethoxy-5-(7-(pyrro...)
Affinity DataIC50: 3.71nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422849(US10508109, Example 40 | N-(1-(2-(5-chloro-2,4- di...)
Affinity DataIC50: 3.81nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422872(US10508109, Example 63 | N-(1-(2-(5-chloro-2,4- di...)
Affinity DataIC50: 3.95nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422847(US10508109, Example 38 | 1-(1-(2-(5-chloro-2,4- di...)
Affinity DataIC50: 4.11nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423052(US10508109, Example 238 | (4-(2-(5-chloro-2,4- dim...)
Affinity DataIC50: 4.16nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422887(US10508109, Example 78 | N1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 4.31nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423003(US10508109, Example 189 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 4.33nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422846(US10508109, Example 37 | N-(1-(2-(5-chloro-2,4- di...)
Affinity DataIC50: 4.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423012(US10508109, Example 198 | dimethyl (1-(2-(5-chloro...)
Affinity DataIC50: 4.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422957(US10508109, Example 143 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 4.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422951(US10508109, Example 137 | 3-(4-(2-(5-chloro-2,4- d...)
Affinity DataIC50: 4.54nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423045(US10508109, Example 231 | 1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 4.88nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422848(US10508109, Example 39 | tert-butyl ((2S)-5-amino-...)
Affinity DataIC50: 4.89nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422871(US10508109, Example 62 | 1-(2-aminoethyl)-3-(1-(2-...)
Affinity DataIC50: 5.14nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422831(US10508109, Example 22 | 2-(5-chloro-2,4- dimethox...)
Affinity DataIC50: 5.15nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423091(US10508109, Example 277 | (methyl(4-((2-(5-chloro-...)
Affinity DataIC50: 5.24nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422889(US10508109, Example 80 | 3-(4-chloro-5-methoxy-2-(...)
Affinity DataIC50: 5.31nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422891(US10508109, Example 82 | 2-(5-chloro-2- (cycloprop...)
Affinity DataIC50: 5.38nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422850(US10508109, Example 41 | (1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 5.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422816(US10508109, Example 7 | 1-(2-(5-bromo-2,4- dimetho...)
Affinity DataIC50: 5.44nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423020(US10508109, Example 206 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 5.61nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423001(US10508109, Example 187 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 5.74nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422859(US10508109, Example 50 | 3-amino-N-(1-(2-(5-chloro...)
Affinity DataIC50: 5.75nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422863(US10508109, Example 54 | N1-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 5.85nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423036(US10508109, Example 222 | N1-(2-(5-chloro-2,4- dim...)
Affinity DataIC50: 5.97nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422908(US10508109, Example 99 | methyl 4-(2-(5-chloro-2,4...)
Affinity DataIC50: 6.06nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422818(US10508109, Example 9 | 2-(5-chloro-2,4- dimethoxy...)
Affinity DataIC50: 6.08nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423054(US10508109, Example 240 | 4-(4-(2-(5-chloro-2,4- d...)
Affinity DataIC50: 6.30nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422832(US10508109, Example 23 | tert-butyl (1-(2-(5-chlor...)
Affinity DataIC50: 6.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423106(US10508109, Example 292 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 6.37nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423015(US10508109, Example 201 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 6.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423016(US10508109, Example 202 | diethyl (2-(4-(2-(5-chlo...)
Affinity DataIC50: 6.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423112(US10508109, Example 298 | (S)-1-(2-(5-chloro-2,4- ...)
Affinity DataIC50: 6.49nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423050(US10508109, Example 236 | (4-(2-(5-chloro-2,4- dim...)
Affinity DataIC50: 6.55nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422913(US10508109, Example 104 | 2-(5-chloro-2,4- dimetho...)
Affinity DataIC50: 6.66nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM422963(US10508109, Example 149 | N-((1-(2-(5-chloro-2,4- ...)
Affinity DataIC50: 6.72nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423069(US10508109, Example 255 | 2-(5-chloro-4-methoxy-2-...)
Affinity DataIC50: 6.72nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase SUV39H2(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM423014(US10508109, Example 200 | 4-(2-(5-chloro-2,4- dime...)
Affinity DataIC50: 6.74nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 316 total ) | Next | Last >>
Jump to: